Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Retreating migraine patients in the second year with monoclonal antibodies anti-CGRP pathway: the multicenter prospective cohort RE-DO study — Fabrizio Vernieri (2023) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Retreating migraine patients in the second year with monoclonal antibodies anti-CGRP pathway: the multicenter prospective cohort RE-DO study
Shared by
Massimo Filippi
Retreating migraine patients in the second year with monoclonal antibodies anti-CGRP pathway: the multicenter prospective cohort RE-DO study
Article
2023
en
Authors
+16 more
FV
Fabrizio Vernieri
NB
Nicoletta Brunelli
SG
Simona Guerzoni
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2025
Three-year treatment with anti-CGRP monoclonal antibodies modifies migraine course: the prospective, multicenter I-GRAINE study
Piero Barbanti
,
Cinzia Aurilia
,
Paola Torelli
,
Gabriella Egeo
,
Florindo d’Onofrio
,
Cinzia Finocchi
,
Antonio Carnevale
,
Giovanna Viticchi
,
Marco Russo
,
Simone Quintana
,
Bianca Orlando
,
Giulia Fiorentini
,
Roberta Messina
,
Marco Bartolini
,
Francesca Pistoia
,
Massimo Filippi
,
Stefano Bonassi
,
Sabina Cevoli
,
Alice Mannocci
Article
2025
Super- and absolute responders to anti-cgrp monoclonal antibodies in migraine: A one-year multicenter, prospective, observational study
Piero Barbanti
,
Cinzia Aurilia
,
Giulia Fiorentini
,
Gabriella Egeo
,
Davide Mascarella
,
Stefania Proietti
,
Roberta Messina
,
Massimo Filippi
,
Stefano Bonassi
,
Paola Torelli
,
Sabina Cevoli
Article
2022
Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients
Piero Barbanti
,
Gabriella Egeo
,
Cinzia Aurilia
,
Claudia Altamura
,
Florindo d’Onofrio
,
Cinzia Finocchi
,
Maria Albanese
,
Marco Aguggia
,
Renata Rao
,
Maurizio Zucco
,
Fabio Frediani
,
Massimo Filippi
,
Roberta Messina
,
Sabina Cevoli
,
Antonio Carnevale
,
Giulia Fiorentini
,
Stefano Messina
,
Francesco Bono
,
Paola Torelli
,
Stefania Proietti
,
Stefano Bonassi
,
Fabrizio Vernieri
Article
2024
Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study
Piero Barbanti
,
Cinzia Aurilia
,
Gabriella Egeo
,
Stefania Proietti
,
Florindo d’Onofrio
,
Paola Torelli
,
Marco Aguggia
,
Davide Bertuzzo
,
Cinzia Finocchi
,
Michele Trimboli
,
Sabina Cevoli
,
Giulia Fiorentini
,
Bianca Orlando
,
Maurizio Zucco
,
Laura Di Clemente
,
Ilaria Cetta
,
Bruno Colombo
,
Monica Laura Bandettini di Poggio
,
Valentina Favoni
,
Licia Grazzi
,
Antonio Salerno
,
Antonio Carnevale
,
Micaela Robotti
,
Article
2023
Late Response to Anti-CGRP Monoclonal Antibodies in Migraine
Piero Barbanti
,
Cinzia Aurilia
,
Gabriella Egeo
,
Paola Torelli
,
Stefania Proietti
,
Sabina Cevoli
,
Stefano Bonassi
,
Giulia Fiorentini Psy
,
Roberta Messina
,
Bruno Colombo
,
Florindo d’Onofrio
,
Maria Albanese
,
Cinzia Finocchi
,
Antonio Salerno
,
B. Mercuri
,
Antonio Carnevale
,
Francesco Bono
,
Fabio Frediani
,
Licia Grazzi
,
Domenico D’Amico
,
Massimo Filippi
,
Claudia Altamura
,
Fabrizio Vernieri
,
Marco Aguggia
,
Davide Bertuzzo
,
Fabio Frediani
,
Claudia Altamura
,
Massimo Filippi
,
Fabrizio Vernieri
,
Stefano Bonassi
Maurizio Zucco
,
Laura Di Clemente
,
Michele Trimboli
,
Valentina Favoni
,
Paola Di Fiore
Discussion(0)
No comments yet. Be the first to comment.